Horng Chen, M.D., is chair, Division of Circulatory Failure, Mayo Clinic in Rochester

Horng Chen, M.D. (I ’97, CV ’01), is the new chair of the Division of Circulatory Failure, Department of Cardiovascular Medicine at Mayo Clinic in Rochester. He succeeds Margaret Redfield, M.D. (I ’87, CV ’91), who was division chair for eight years.

Dr. Chen is an NIH-funded clinician investigator who has advanced the field of preclinical heart failure and cardiorenal therapeutics. He is co-director of the Mayo Clinic CardioRenal Research Laboratory and has been continuously funded by the National Institutes of Health since 2005, currently holding 2 NIH RO1 grants. Dr. Chen has been awarded seven patents and is co-founder of Zumbro Discovery, a biotech company formed by Mayo Medical Ventures and Broadview Ventures. He also has been involved in the clinical development of two other Mayo biotech companies. He has more than 130 publications and was the national principal investigator, leading a multi-center clinical trial “ROSE study” performed within the NHLBI Heart Failure Clinical Research Network. Dr. Chen is associate director of the NIH/NHLBI Cardiovasology T32 Training Grant.

Dr. Chen is a professor of medicine in the Mayo Clinic College of Medicine and Science.

Recommended reading

Posts about similar topics: